Oxford Fundamentals

OXBDF
 Stock
  

USD 4.16  0.12  2.97%   

Oxford Biomedical fundamentals help investors to digest information that contributes to Oxford Biomedical's financial success or failures. It also enables traders to predict the movement of Oxford OTC Stock. The fundamental analysis module provides a way to measure Oxford Biomedical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Oxford Biomedical otc stock.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  

Oxford Return On Equity Analysis

Oxford Biomedical's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Return on Equity 
 = 
Net Income 
Total Equity 
X
100 
More About Return On Equity | All Equity Analysis

Current Oxford Biomedical Return On Equity

    
  (13.60) %  
Most of Oxford Biomedical's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Oxford Biomedical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Compare to competition

Based on the latest financial disclosure, Oxford Biomedical has a Return On Equity of -13.6%. This is 43.26% lower than that of the Healthcare sector and 62.7% lower than that of the Biotechnology industry. The return on equity for all United States stocks is notably higher than that of the company.

Oxford Biomedical Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Oxford Biomedical's current stock value. Our valuation model uses many indicators to compare Oxford Biomedical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Oxford Biomedical competition to find correlations between indicators driving Oxford Biomedical's intrinsic value. More Info.
Oxford Biomedical is considered to be number one stock in z score category among related companies. It is considered to be number one stock in return on asset category among related companies . . Comparative valuation analysis is a catch-all model that can be used if you cannot value Oxford Biomedical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Oxford Biomedical's OTC Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Oxford Biomedical's earnings, one of the primary drivers of an investment's value.

Oxford Profit Margin Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Oxford Biomedical's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Oxford Biomedical could also be used in its relative valuation, which is a method of valuing Oxford Biomedical by comparing valuation metrics of similar companies.
Oxford Biomedical is currently under evaluation in profit margin category among related companies.

Oxford Fundamentals

About Oxford Biomedical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Oxford Biomedical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Oxford Biomedical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Oxford Biomedical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Oxford Biomedica plc, a biopharmaceutical company, engages in the research, development, and bioprocessing of cell and gene therapy products in Europe and internationally. Oxford Biomedica plc was founded in 1995 and is headquartered in Oxford, the United Kingdom. Oxford Biomedical operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 959 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Oxford Biomedical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Oxford Biomedical's short interest history, or implied volatility extrapolated from Oxford Biomedical options trading.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Oxford Biomedical using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please check Oxford Biomedical Piotroski F Score and Oxford Biomedical Altman Z Score analysis. Note that the Oxford Biomedical information on this page should be used as a complementary analysis to other Oxford Biomedical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Oxford OTC Stock analysis

When running Oxford Biomedical price analysis, check to measure Oxford Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oxford Biomedical is operating at the current time. Most of Oxford Biomedical's value examination focuses on studying past and present price action to predict the probability of Oxford Biomedical's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Oxford Biomedical's price. Additionally, you may evaluate how the addition of Oxford Biomedical to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Is Oxford Biomedical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oxford Biomedical. If investors know Oxford will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oxford Biomedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Oxford Biomedical is measured differently than its book value, which is the value of Oxford that is recorded on the company's balance sheet. Investors also form their own opinion of Oxford Biomedical's value that differs from its market value or its book value, called intrinsic value, which is Oxford Biomedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oxford Biomedical's market value can be influenced by many factors that don't directly affect Oxford Biomedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Oxford Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine Oxford Biomedical value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oxford Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.